81 – 90 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
- Contribution to journal › Article
-
Mark
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
- Contribution to journal › Article
-
Mark
A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies
- Contribution to journal › Article
-
Mark
Alzheimer's pathology targets distinct memory networks in the ageing brain
- Contribution to journal › Article
-
Mark
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum
- Contribution to journal › Article
-
Mark
Distinct Conformations, Aggregation and Cellular Internalization of Different Tau Strains
- Contribution to journal › Article
- 2018
-
Mark
Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease : a cohort study
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
(2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018
- Contribution to conference › Abstract
